Ningbo Menovo Pharm Co Ltd (603538) — Capital Reinvestment Ratio

Latest as of September 2025: 0.12x

Ningbo Menovo Pharm Co Ltd (603538) has a Capital Reinvestment Ratio of 0.12x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥38.86 Million) in capital expenditures (CN¥4.60 Million). See Ningbo Menovo Pharm Co Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.12x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥38.86 Million
CNY

Capital Expenditures

CN¥4.60 Million
CNY

Data as of

Sep 2025
Most recent filing

Ningbo Menovo Pharm Co Ltd Capital Reinvestment Ratio (2011–2025)

This chart tracks Ningbo Menovo Pharm Co Ltd's Capital Reinvestment Ratio across 15 annual periods.

Annual Capital Reinvestment Ratio for Ningbo Menovo Pharm Co Ltd (2011–2025)

Year-by-year Capital Reinvestment Ratio for Ningbo Menovo Pharm Co Ltd from 2011 to 2025. For live market cap and broader valuation context, see 603538 company net worth.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2025 0.71x CN¥157.56 Million CN¥112.08 Million ▼ -61.3%
2024 1.84x CN¥97.54 Million CN¥179.40 Million ▼ -92.3%
2023 24.04x CN¥9.13 Million CN¥219.54 Million ▲ +1064.7%
2022 2.06x CN¥276.95 Million CN¥571.62 Million ▼ -14.1%
2021 2.40x CN¥220.63 Million CN¥529.89 Million ▲ +93.8%
2020 1.24x CN¥251.61 Million CN¥311.74 Million ▼ -32.1%
2019 1.83x CN¥179.75 Million CN¥328.07 Million ▼ -71.6%
2018 6.43x CN¥46.60 Million CN¥299.59 Million ▲ +497.7%
2017 1.08x CN¥80.15 Million CN¥86.22 Million ▲ +15.9%
2016 0.93x CN¥117.24 Million CN¥108.84 Million ▲ +101.2%
2015 0.46x CN¥133.42 Million CN¥61.56 Million ▼ -24.8%
2014 0.61x CN¥75.22 Million CN¥46.14 Million ▲ +21.3%
2013 0.51x CN¥149.21 Million CN¥75.44 Million ▼ -76.4%
2012 2.14x CN¥38.11 Million CN¥81.72 Million ▲ +63.4%
2011 1.31x CN¥121.67 Million CN¥159.71 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow